Ultragenyx Pharmaceutical reported $-82776000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -43709000 23.06M
Acceleron Pharma XLRN:US $ -63662000 59K
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Aptinyx Inc APTX:US $ -19866000 5.58M
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -240791000 9.95M
Epizyme EPZM:US $ -58231000 6.11M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Insmed INSM:US $ -88566000 4.73M
IONIS PHARMACEUT IONS:US $ -72969000 19M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Kyowa Hakko Kirin 4151:JP 15.11B 148M
Macrogenics MGNX:US $ -40279000 11.01M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Ptc Therapeutics PTCT:US $ -98493000 345K
Puma Biotechnology PBYI:US $ -16633000 36.78M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Vital Therapies VTL:US $ -19170000 13.22M
Xoma XOMA:US $ -3064000 3.36M